PREPL p.Arg421Gln
c.1262G>A · rs754572953 · VCV650135
Computational evidence
| Protein change | ||
| AlphaMissense | 0.6971 | likely pathogenic |
|---|---|---|
| REVEL | 0.521 | indeterminate |
| SaProt | LLR -12.91 | damaging |
| ⇒ AlphaMissense and SaProt both call this damaging; REVEL is indeterminate. | ||
| Splicing | ||
| SpliceAI | Δ0.34 | donor loss · deltas |
| Pangolin | Δ0.69 | loss · gain 0.28 · agrees with SpliceAI · independent |
| Constraint at this position | ||
| Conservation | phyloP 7.7 | GERP 2.8, phastCons 1 |
| Regional constraint | o/e 1.29 | unconstrained · MANE · 25 kb · p 1e-15 · regional, not allelic |
| Overall | ||
| CADD | 35.0 | PHRED · no single calibrated threshold — expert panels disagree |
ClinVar classifies this uncertain; the computational predictors unanimously lean damaging — a triage signal, not a reclassification
AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.
⚠ Isoform check: AlphaMissense numbered on a different transcript (AM R510Q vs ClinVar R421Q) — verify the residue.
Population frequency
| Ancestry group | Frequency | 1 in |
|---|---|---|
| Middle Easterngrpmax | 0.0166% | 6,032 |
| East Asian | 0.0111% | 8,971 |
| Remaining individualsnot grpmax-eligible | 0.00481% | 20,771 |
| European (non-Finnish) | 0.00246% | 40,628 |
| South Asian | 0.00111% | 89,752 |
Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.
Variant & gene context
- Gene
- PREPL
- Protein
- p.Arg421Gln
- Coding
- c.1262G>A
- MANE Select
- NM_001171613
- dbSNP
- rs754572953
- Type
- single nucleotide variant
- Location
- chr2:44328937 (GRCh38)
- Gene constraint
- LOEUF 1.247 · pLI <0.01 · ClinGen HI gene assoc. with recessive phenotype (gnomAD)
- Structure
- AlphaFold pLDDT 82.46 · 2 PDB
- Residue 510 UniProt numbering
- a UniProt-annotated variant site (found in a patient with intellectual disability, short stature, chronic lung disease and failure to thrive; uncertain significance)
Disease context
myasthenic syndrome, congenital, 22 — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatmentsFor Congenital myasthenic syndrome (Orphanet):
- Inheritance
- Autosomal dominant, Autosomal recessive
- Onset
- Infancy, Neonatal
- Prevalence
- 1-9 / 1 000 000 (Europe)
Similar variants
- PREPL p.Arg421Ter Pathogenic ★ same residue
- PREPL c.1262+1G>A Pathogenic/Likely pathogenic ★★ same condition
- PREPL c.1263-1G>C Pathogenic/Likely pathogenic ★★ same condition
- PREPL c.-49+1734C>T Pathogenic/Likely pathogenic ★★ same condition
- PREPL p.Arg206Ter Pathogenic/Likely pathogenic ★★ same condition
- PREPL p.Gln14Ter Pathogenic/Likely pathogenic ★★ same condition
- PREPL p.Gln456Ter Pathogenic/Likely pathogenic ★★ same condition
- PREPL p.Glu577Ter Pathogenic ★★ same condition
Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →
Cite Sugi Variant
Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/prepl-p-arg421gln (accessed [today's date]).
Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown